Completed NA INTERVENTIONAL 2-arm NCT03107169

Treatment of Initial Clostridium Difficile Infection

Fecal Microbiota Transplant Versus Vancomycin for Treatment of Initial Clostridium Difficile Infection

Sponsor: Universidad Autonoma de Nuevo Leon

Conditions Clostridium Difficile Infection

Updated 5 times since 2017 Last updated: Apr 15, 2017 Started: Feb 1, 2015 Primary completion: Sep 30, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Clostridium Difficile Infection and is currently completed. Universidad Autonoma de Nuevo Leon leads this study, which shows 5 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
May 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad Autonoma de Nuevo Leon

Data source: Universidad Autonoma de Nuevo Leon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.